KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Scientists have found a way to make perovskite solar cells not only highly efficient but also remarkably stable, addressing ...

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

Researchers at the Massachusetts Institute of Technology (MIT) have synthesised for the first time a complex fungal compound ...

Octopus and other cephalopods are good at hiding themselves—and are inspiring cutting-edge technologies that may help us do ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

Plants have an extraordinary ability to sense tissue damage and quickly rebuild their protective outer layers, a process ...

Mitochondria convert food into energy, and researchers led by Tristan Rawling study mitochondrial uncouplers—molecules that reduce efficiency, making cells burn more fat—aiming to improve metabolic ...